Development of pacemaker properties and rhythmogenic mechanisms in the mouse embryonic respiratory network

  1. Marc Chevalier
  2. Natalia Toporikova
  3. John Simmers
  4. Muriel Thoby-Brisson  Is a corresponding author
  1. Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS UMR 5287, France
  2. Washington and Lee University, United States

Abstract

Breathing is a vital rhythmic behavior generated by hindbrain neuronal circuitry, including the preBötzinger complex network (preBötC) that controls inspiration. The emergence of preBötC network activity during prenatal development has been described but little is known regarding inspiratory neurons expressing pacemaker properties at embryonic stages. Here, we combined calcium imaging and electrophysiological recordings in mouse embryo brainstem slices together with computational modeling to reveal the existence of heterogeneous pacemaker oscillatory properties relying on distinct combinations of burst-generating INaP and ICAN conductances. The respective proportion of the different inspiratory pacemaker subtypes changes during prenatal development. Concomitantly, network rhythmogenesis switches from a purely INaP/ICAN-dependent mechanism at E16.5 to a combined pacemaker/network-driven process at E18.5. Our results provide the first description of pacemaker bursting properties in embryonic preBötC neurons and indicate that network rhythmogenesis undergoes important changes during prenatal development through alterations both in circuit properties and the biophysical characteristics of pacemaker neurons.

Article and author information

Author details

  1. Marc Chevalier

    Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS UMR 5287, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Natalia Toporikova

    Department of Biology, Washington and Lee University, Lexington, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. John Simmers

    Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS UMR 5287, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Muriel Thoby-Brisson

    Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, CNRS UMR 5287, Bordeaux, France
    For correspondence
    muriel.thoby-brisson@u-bordeaux.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3214-1724

Funding

Agence Nationale pour le Développement de la Recherche en Santé (ANR12-BSV4-0011-01)

  • Muriel Thoby-Brisson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ronald L Calabrese, Emory University, United States

Ethics

Animal experimentation: All experiments were performed in accordance with the guidelines of the European and French National legislation on animal experimentation and the local ethics committee of the University of Bordeaux (permit number 5012031A)

Version history

  1. Received: March 17, 2016
  2. Accepted: July 18, 2016
  3. Accepted Manuscript published: July 19, 2016 (version 1)
  4. Version of Record published: August 18, 2016 (version 2)

Copyright

© 2016, Chevalier et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,322
    Page views
  • 295
    Downloads
  • 20
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marc Chevalier
  2. Natalia Toporikova
  3. John Simmers
  4. Muriel Thoby-Brisson
(2016)
Development of pacemaker properties and rhythmogenic mechanisms in the mouse embryonic respiratory network
eLife 5:e16125.
https://doi.org/10.7554/eLife.16125

Share this article

https://doi.org/10.7554/eLife.16125

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.